Indeed, the sEH inhibitor AUDA increases EET levels, enhancing the neuronal viability, suggesting a neuroprotectant role of EET in the brain after an oxidative environment in brain, as occurs in PD or other neurodegenerative diseases. This evidence concerns the gene EPHX2 and neurodegenerative disease.